Full-Time

Facilities Maintenance Planner & Scheduler

Posted on 4/3/2025

Abzena

Abzena

201-500 employees

Supports biopharmaceutical development and manufacturing

No salary listed

Mid, Senior

Bristol, PA, USA

Category
Lab & Research
Life Sciences
Required Skills
SAP Products
Word/Pages/Docs
Customer Service
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Minimum of four (4) years of GMP or facilities management experience.
  • Proficient skills with CMMS software, such as Blue Mountain Ram, SAP, Maximo or equivalent.
  • Work with the QA and facilities functions to generate, investigate, and close deviations, CAPAs and Change Controls in a GMP environment. Experience from regulated industries such as the food, chemical and nuclear environments is also applicable.
  • Ability to work and communicate professionally, both verbally and in written form with internal and external customers, colleagues and contractors.
  • Ability to demonstrate customer service excellence.
  • Proficient knowledge of Excel, Outlook, Word and PowerPoint.
  • Knowledge of GMP controlled environment monitoring.
  • Ability to organize and manage multiple projects simultaneously.
  • Ability to perform and manage technically complex projects using independent judgment and personal initiative.
  • Ability to work independently.
  • Ability to complete projects and tasks within deadlines.
  • Ability to recognize opportunities and adjust direction when the situation warrants.
Responsibilities
  • Process all work requests triaging them before converting them to work orders if required. Plans work by procuring materials, identifies and assigns resources to the work. Schedules the work by securing assets and areas with area owners, safety and quality assurance as required for safe compliant work execution.
  • Plans, schedules and executes site shutdowns coordinating the facilities team and contractors, bundling work appropriately to minimize business disruption.
  • Uses the CMMS exclusively in execution of all work on site.
  • Generate work look ahead in accordance using the CMMS coordinating internal and external resources and areas to execute work within established due dates.
  • Generate and monitor maintenance KPIs (Key Performance Indicators) on a regular basis to drive maintenance and calibration compliance and improvements.
  • Supports and coordinates equipment installation and qualifications in support of equipment procurement site wide.
  • Works with other facilities team members to initiate, investigate and close deviations, CAPAS and change controls in a GMP environment as required.
  • Schedules and coordinates routine and emergent license to operate testing including fire protection, pressure relief device testing, back flow preventer testing and all other relevant inspections.
  • Support the Manager of Engineering and Facilities with external contracts, as needed including onboarding new contractors and vendors as needed in support of work and project execution.
  • Assists the Facilities team in capital project execution as required.
  • Represent the Facilities group in meetings to give accounting of facility readiness and schedule work as required.
  • Participate in site on call program with facilities team as required.
  • Performs other related duties as assigned.
  • Operates to the highest ethical and moral standards.
  • Complies with Abzena’s policies and procedures.
  • Adheres to quality standards set by regulations and Abzena policies, procedures, and mission.
  • Communicates effectively with supervisors, colleagues, and staff.
  • Ability to participate effectively as a team player in all aspects of Abzena’s business.
  • Travel as needed between sites, to attend professional conferences, and train on new technologies.

Abzena supports the development and manufacturing of biopharmaceutical products, working with clients such as biopharmaceutical companies and academic groups globally. The company provides a range of services that cover the entire drug development process, from discovery to clinical development, with a focus on biologics, which are drugs derived from living organisms. Abzena's offerings include custom synthesis, high-potency active pharmaceutical ingredient (HPAPI) synthesis, and antibody-drug conjugate (ADC) manufacturing, among others. What sets Abzena apart from competitors is its comprehensive suite of specialized services and proprietary technologies that facilitate the creation of effective treatments. The company's goal is to help clients develop better therapies for patients while establishing long-term partnerships that generate recurring revenue.

Company Size

201-500

Company Stage

IPO

Headquarters

Babraham, United Kingdom

Founded

2001

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for ADCs boosts Abzena's manufacturing service opportunities.
  • Expansion of GMP cell-based potency testing strengthens Abzena's regulatory compliance.
  • Personalized medicine trends increase demand for Abzena's custom synthesis services.

What critics are saying

  • Emerging CDMOs may erode Abzena's market share.
  • Regulatory approval delays could hinder Abzena's innovation market entry.
  • Talent shortages in bioconjugation may affect Abzena's operational efficiency.

What makes Abzena unique

  • Abzena offers end-to-end services for complex biologics and bioconjugates.
  • The company provides unique ADC manufacturing and bioconjugation capabilities.
  • Abzena's EpiScreen 2.0 tool enhances immunogenicity assessment for biologics and bioconjugates.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-3%
PR Newswire
Feb 26th, 2025
Abzena Strengthens Executive Leadership Team With The Appointment Of Taylor Boyd As Cbo

SAN DIEGO, Calif., Feb. 26, 2025 /PRNewswire/ -- Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has announced today that Taylor Boyd has joined the company as its Chief Business Officer ("CBO"). In this newly created role, Boyd will be responsible for corporate development, portfolio strategy, and partnering strategy activities that drive Abzena's continued commitment to innovation and growth

Contract Pharma
Feb 26th, 2025
Abzena Appoints Taylor Boyd as CBO

Abzena, an integrated CDMO + CRO for complex biologics and bioconjugates, has named Taylor Boyd Chief Business Officer.

CityBiz
Jan 8th, 2025
Abzena Appoints Dr Moncef Slaoui to Board

SAN DIEGO, Jan. 8, 2025 /PRNewswire/ - Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has today announced the appointment of Dr Moncef Slaoui, PhD, to its Board of Directors.

PR Newswire
Jan 8th, 2025
Abzena Strengthens Board With Appointment Of Biopharma Industry Leader, Dr Moncef Slaoui

SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has today announced the appointment of Dr Moncef Slaoui, PhD, to its Board of Directors. A highly accomplished leader in the biopharmaceutical industry with over 40 years' experience, Dr Slaoui has held numerous executive leadership and board level positions, to help drug development companies through high phases of growth.Matt Stober, CEO of Abzena said, "Dr Slaoui's exceptional track record of leadership and expertise in product innovation will be extremely valuable as we continue to grow and position ourselves as the leading drug development and manufacturing organization for complex biologics and bioconjugates. We welcome him to our board and look forward to leveraging his extensive experience in supporting high–growth pharmaceutical businesses.""I am thrilled to be joining Abzena's Board of Directors," said Slaoui. "Abzena is a true innovator in the CRO and CDMO space, and I look forward to helping them develop new technologies and platforms that enable the better delivery of next gen therapeutics.""I am delighted that Moncef has accepted this position," said Geoffrey Glass, Chairman of Abzena's Board. "Moncef brings a set of highly relevant skills and experience to the board, and I look forward to working with him and our executive team as we support Abzena through its next stage of growth."Dr Moncef Slaoui currently serves as an advisor to Medicxi and is on the Board of Directors of several companies including Cedar Health, Arcturus Therapeutics, Altesa, Zephyr AI and Vicebio

PR Newswire
Nov 19th, 2024
Abzena Expands Analytical Capabilities To Include Gmp Cell-Based Potency Testing Across Us Uk Sites

CAMBRIDGE, England and SAN DIEGO, Nov. 19, 2024 /PRNewswire/ -- Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, announced the expansion of their early and late-phase analytical capabilities to now include GMP cell-based potency assays at their Cambridge, UK and San Diego, CA development and manufacturing facilities. The expansion enhances Abzena's extensive bioassay offering, providing customers with a more comprehensive, streamlined, and cost-effective way to access critical data faster. GMP cell-based potency assays play an essential role in quantitatively measuring the biological activity of a biopharmaceutical, and the cytotoxicity of the payload of an Antibody-drug conjugate (ADC), for both GMP product release and stability testing. By adding this capability to their global toolkit, Abzena will be able to provide precise and reliable data on drug potency, alongside developability and characterization data including mechanism of action (MOA) and immunogenicity, which are essential for regulatory submissions. Dr Campbell Bunce, CSO and Cambridge Site Head at Abzena said, "We recognize that high-quality data is the cornerstone of effective decision-making

INACTIVE